BACKGROUND: The major sites of obstruction in chronic obstructive pulmonary disease (COPD) are small airways (<2 mm in diameter). We wanted to determine whether there was a relationship between small-airway obstruction and emphysematous destruction in COPD. METHODS: We used multidetector computed tomography (CT) to compare the number of airways measuring 2.0 to 2.5 mm in 78 patients who had various stages of COPD, as judged by scoring on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) scale, in isolated lungs removed from patients with COPD who underwent lung transplantation, and in donor (control) lungs. MicroCT was used to measure the extent of emphysema (mean linear intercept), the number of terminal bronchioles per milliliter of lung volume, and the minimum diameters and cross-sectional areas of terminal bronchioles. RESULTS: On multidetector CT, in samples from patients with COPD, as compared with control samples, the number of airways measuring 2.0 to 2.5 mm in diameter was reduced in patients with GOLD stage 1 disease (P=0.001), GOLD stage 2 disease (P=0.02), and GOLD stage 3 or 4 disease (P<0.001). MicroCT of isolated samples of lungs removed from patients with GOLD stage 4 disease showed a reduction of 81 to 99.7% in the total cross-sectional area of terminal bronchioles and a reduction of 72 to 89% in the number of terminal bronchioles (P<0.001). A comparison of the number of terminal bronchioles and dimensions at different levels of emphysematous destruction (i.e., an increasing value for the mean linear intercept) showed that the narrowing and loss of terminal bronchioles preceded emphysematous destruction in COPD (P<0.001). CONCLUSIONS: These results show that narrowing and disappearance of small conducting airways before the onset of emphysematous destruction can explain the increased peripheral airway resistance reported in COPD. (Funded by the National Heart, Lung, and Blood Institute and others.).
BACKGROUND: The major sites of obstruction in chronic obstructive pulmonary disease (COPD) are small airways (<2 mm in diameter). We wanted to determine whether there was a relationship between small-airway obstruction and emphysematous destruction in COPD. METHODS: We used multidetector computed tomography (CT) to compare the number of airways measuring 2.0 to 2.5 mm in 78 patients who had various stages of COPD, as judged by scoring on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) scale, in isolated lungs removed from patients with COPD who underwent lung transplantation, and in donor (control) lungs. MicroCT was used to measure the extent of emphysema (mean linear intercept), the number of terminal bronchioles per milliliter of lung volume, and the minimum diameters and cross-sectional areas of terminal bronchioles. RESULTS: On multidetector CT, in samples from patients with COPD, as compared with control samples, the number of airways measuring 2.0 to 2.5 mm in diameter was reduced in patients with GOLD stage 1 disease (P=0.001), GOLD stage 2 disease (P=0.02), and GOLD stage 3 or 4 disease (P<0.001). MicroCT of isolated samples of lungs removed from patients with GOLD stage 4 disease showed a reduction of 81 to 99.7% in the total cross-sectional area of terminal bronchioles and a reduction of 72 to 89% in the number of terminal bronchioles (P<0.001). A comparison of the number of terminal bronchioles and dimensions at different levels of emphysematous destruction (i.e., an increasing value for the mean linear intercept) showed that the narrowing and loss of terminal bronchioles preceded emphysematous destruction in COPD (P<0.001). CONCLUSIONS: These results show that narrowing and disappearance of small conducting airways before the onset of emphysematous destruction can explain the increased peripheral airway resistance reported in COPD. (Funded by the National Heart, Lung, and Blood Institute and others.).
Authors: Alejandro A Diaz; Clarissa Valim; Tsuneo Yamashiro; Raúl San José Estépar; James C Ross; Shin Matsuoka; Brian Bartholmai; Hiroto Hatabu; Edwin K Silverman; George R Washko Journal: Chest Date: 2010-06-17 Impact factor: 9.410
Authors: Annette M McWilliams; John R Mayo; Myeong Im Ahn; Sharyn L S MacDonald; Stephen C Lam Journal: J Thorac Oncol Date: 2006-01 Impact factor: 15.609
Authors: Stephen Lam; Jean C leRiche; Annette McWilliams; Calum Macaulay; Yulia Dyachkova; Eva Szabo; John Mayo; Robert Schellenberg; Andy Coldman; Ernest Hawk; Adi Gazdar Journal: Clin Cancer Res Date: 2004-10-01 Impact factor: 12.531
Authors: Stephen Lam; Calum MacAulay; Jean C Le Riche; Yulia Dyachkova; Andy Coldman; Martial Guillaud; Ernest Hawk; Marie-Odile Christen; Adi F Gazdar Journal: J Natl Cancer Inst Date: 2002-07-03 Impact factor: 13.506
Authors: Antoine A Robbesom; Elly M M Versteeg; Jacques H Veerkamp; J Han J M van Krieken; Hans J Bulten; Hans T J Smits; Luuk N A Willems; Cees L A van Herwaarden; P N Richard Dekhuijzen; Toin H van Kuppevelt Journal: Mod Pathol Date: 2003-01 Impact factor: 7.842
Authors: J Stolk; W Broekman; T Mauad; J J Zwaginga; H Roelofs; W E Fibbe; J Oostendorp; I Bajema; M I M Versteegh; C Taube; P S Hiemstra Journal: QJM Date: 2016-01-27
Authors: Sandeep Bodduluri; Arie Nakhmani; Joseph M Reinhardt; Carla G Wilson; Merry-Lynn McDonald; Ramaraju Rudraraju; Byron C Jaeger; Nirav R Bhakta; Peter J Castaldi; Frank C Sciurba; Chengcui Zhang; Purushotham V Bangalore; Surya P Bhatt Journal: JCI Insight Date: 2020-07-09
Authors: Dragoş M Vasilescu; André B Phillion; Daisuke Kinose; Stijn E Verleden; Bart M Vanaudenaerde; Geert M Verleden; Dirk Van Raemdonck; Christopher S Stevenson; Cameron J Hague; MeiLan K Han; Joel D Cooper; Tillie-Louise Hackett; James C Hogg Journal: J Appl Physiol (1985) Date: 2020-04-16
Authors: G R Washko; A A Diaz; V Kim; R G Barr; M T Dransfield; J Schroeder; J J Reilly; J W Ramsdell; A McKenzie; E J R Van Beek; D A Lynch; J P Butler; M K Han Journal: J Appl Physiol (1985) Date: 2014-01-16
Authors: Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg Journal: Lancet Respir Med Date: 2020-02-13 Impact factor: 30.700